Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical modelsSumer Jasmine(Johns Hopkins University), W. Nathaniel Brennen(Johns Hopkins University)The ProstateApril 15, 202410.1002/pros.24707Cited by 10SaveCiteExport RISWatch citationsRelated PapersTasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment|Cancer Research|2012|113